Navigation Links
Callisto Reports on Second-Quarter 2007 Milestones
Date:8/19/2007

hetic molecule) of uroguanylin developed by Callisto scientists, and is proprietary to Callisto. Guanilib has been demonstrated to be superior to uroguanylin in its biological activity, protease stability and pH characteristics, and is currently undergoing pre-clinical animal studies as a treatment for gastrointestinal (GI) diseases and GI inflammation. Animal model data on Guanilib previously demonstrated anti-inflammatory activity in a number of mouse-models of ulcerative colitis, and the drug is currently being evaluated in animal models of GI disorders. Callisto plans to initiate clinical trials of Guanilib in early 2008.

About Atiprimod

Atiprimod is an orally bio-available small molecule drug that displays multiple mechanisms of action. The drug has been shown to be antiangiogenic, inhibit secretion of VEGF and IL-6, elicit an apoptotic response (programmed cellular death), and inhibit phosphorylation of key kinases involved in tumor progression and survival including Akt and STAT3. The drug is presently in two clinical trials: a Phase II trial in advanced carcinoid cancer patients, and a Phase I/IIa human clinical trial in relapsed or refractory multiple myeloma patients.

About Callisto Pharmaceuticals, Inc.

Callisto is a biopharmaceutical company focused on the development of new drugs to treat various forms of cancer and gastrointestinal diseases. Callisto's drug candidates in development currently include anti-cancer agents in clinical development, in addition to drugs in pre-clinical development for other significant health care markets, including gastrointestinal disorders. One of the Company's lead drug candidates, Atiprimod is presently in a Phase II clinical trial in advanced carcinoid cancer patients, a neuroendocrine tumor, and in a Phase I/IIa human clinical trial in relapsed or refractory multiple myeloma patients. Another anti-cancer drug, L-Annamycin, is being developed as a treatment for forms of relapsed or refractory ac
'/>"/>

SOURCE Callisto Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Callisto Pharmaceuticals Announces Publication of Research Article on Atiprimod Preclinical Studies in Mantle Cell Lymphoma
2. Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis
3. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
4. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
5. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
6. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
7. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
8. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
9. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
10. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
11. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Today, humanity takes a massive step toward reaching our shared ... CONTACTS announces their new Apple Watch app which allows the ... Two taps. New contacts. From your watch. We live ... LensGauge which helps keep track of how long your lenses ... "Since our inception, we,ve been dedicated to providing our ...
(Date:4/24/2015)... , April 24, 2015  Bayer Corporation hosted its ... 23 at the Bayer HealthCare US headquarters.  This is Bayer,s ... the Whippany campus, and Thursday,s event ... do every day at work. Fortunately, for the ... As a company whose mission is "Science For A Better ...
(Date:4/24/2015)... April 24, 2015 In today,s ever-changing ... groups around the world to access diverse skill ... While there are many areas to misstep in ... which best practices are necessary and beneficial in ... According to research by benchmarking firm, Best ...
Breaking Medicine Technology:Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4Work Around the Clock: Building Effective Global Capabilities 2
... 1, 2011 Please replace the release dated August ... second and third sentences added and should read: The ... will be filed in a Form 8K with the ... on Friday, September 9, 2011.  This presentation will also ...
... 1, 2011 GeoVax Labs, Inc. (OTCQB/OTCBB: ... and fight Human Immunodeficiency Virus (HIV) infections, today announced ... to $4.4 million for its Integrated Preclinical/Clinical AIDS Vaccine ... This five-year grant was originally awarded in 2007 ...
Cached Medicine Technology:UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September 2UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September 3GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government 2GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government 3
(Date:4/26/2015)... Orlando, FL (PRWEB) April 26, 2015 ... States, pioneered in delivering valuable community services to the ... several developmental projects in India for more than two ... served hundreds and thousands of subscribers around the world ... such source at that time. The Immigration Law Forum ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 Forbes Living ... The city is one which is synonymous with clean beaches, ... trade, and education are major economic influencers in the city ... the dynamic talk show are pleased to announce the show ... April 26 at 3:00 PM PDT. Tune in to find ...
(Date:4/25/2015)... 2015 The National League for ... national endeavor to prepare nurses to provide high quality, ... success, according to a new report by the John ... partners. , The project began in 2007 as ... the direction of Elaine Tagliareni, EdD, RN, CNE, FAAN, ...
(Date:4/25/2015)... D.C. (PRWEB) April 25, 2015 In ... worldwide will join The Million Nets Pledge, a two-year ... campaign to protect refugee families with one million bednets ... their increased work with UN partners to protect children, ... from malaria. , “There has been a large ...
(Date:4/25/2015)... York (PRWEB) April 25, 2015 ... for vaginal mesh lawsuits filed against C.R. Bard, ... District Court, Southern District of West Virginia. According ... Scheduling Conference was convened that day, after certain ... Long Form Complaint. The Order directed that any ...
Breaking Medicine News(10 mins):Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 2Health News:North American Telugu Society Bestows Community Service Award to India Network Foundation for Its Generosity and Sponsor of Visitor Health Insurance to Indian Visitors 3Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4
... , CINCINNATI, Dec. 8, 2009 ... ) today announced the appointment of Angela F. Braly ... (NYSE: WLP ), to its board of ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20091208/CL22979-a ) , (Photo: ...
... Registration is open for the 2010 AIUM Annual Convention ... the United States dedicated to all disciplines of medical ... Diego, California. The 2010 Annual Convention focuses on emerging ... scientists, and manufacturers as ultrasound continues to advance and ...
... Scripps Research Institute have determined the structure of a critical ... of the deadliest viruses on the planet killing between 50 ... online Early Edition of the journal Proceedings of the ... reveals how a key component of the Ebola virus, called ...
... could lead to better diagnoses, experts say , TUESDAY, Dec. ... as it beats, and a German study shows how the ... and old. , In the study, published in the Dec. ... at University Hospital Freiburg describe the different heartbeats they saw ...
... high-flow oxygen treatment , TUESDAY, Dec. 8 (HealthDay ... treatment for cluster headaches, British researchers have found. , ... eight per day in bouts that last for weeks ... drug sumatriptan, but frequent use of the drug isn,t ...
... not aggression, researchers say, , TUESDAY, Dec. 8 (HealthDay ... male sex hormone actually encourages a sense of fair ... cause aggression, said lead researcher Michael Naef, of the ... But it does lead to "status-seeking behavior -- or ...
Cached Medicine News:Health News:Procter & Gamble Announces Appointment of Director 2Health News:AIUM gears up for 2010 Annual Convention in San Diego, California 2Health News:Scripps Research scientists reveal key structure from ebola virus 2Health News:Beating Heart Differs by Gender, Age: Study 2Health News:Oxygen Therapy May Relieve Cluster Headache Pain 2Health News:Testosterone Gets Bad Rap: Study 2Health News:Testosterone Gets Bad Rap: Study 3
Athouritative, on the spot answers for acute care and consultations....
... The SphygmoCor Mx Central Blood Pressure ... the SphygmoCor Px system by providing ... pressure waveform., ,Key cardiovascular parameters are ... These parameters include:, Central Systolic, ...
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Medicine Products: